↓ Skip to main content

Dove Medical Press

Article Metrics

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, July 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)

Mentioned by

twitter
1 tweeter
googleplus
1 Google+ user

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
34 Mendeley
Title
Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
Published in
ClinicoEconomics and Outcomes Research: CEOR, July 2013
DOI 10.2147/ceor.s42755
Pubmed ID
Authors

Josep Darba, Nuria Pérez-Álvarez, Lisette Kaskens, Susana Holgado-Pérez, Javier Rejas, Racketa

Abstract

The purpose of this study was to assess the cost-effectiveness of bazedoxifene and raloxifene for prevention of vertebral and nonvertebral fractures among postmenopausal Spanish women aged 55-82 years with established osteoporosis and a high fracture risk.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 3%
Spain 1 3%
India 1 3%
Unknown 31 91%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 26%
Student > Bachelor 5 15%
Researcher 4 12%
Professor > Associate Professor 3 9%
Student > Master 3 9%
Other 6 18%
Unknown 4 12%
Readers by discipline Count As %
Medicine and Dentistry 14 41%
Economics, Econometrics and Finance 5 15%
Pharmacology, Toxicology and Pharmaceutical Science 3 9%
Mathematics 2 6%
Computer Science 1 3%
Other 2 6%
Unknown 7 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 August 2013.
All research outputs
#2,007,241
of 4,505,550 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#93
of 156 outputs
Outputs of similar age
#38,844
of 93,038 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#14
of 16 outputs
Altmetric has tracked 4,505,550 research outputs across all sources so far. This one has received more attention than most of these and is in the 53rd percentile.
So far Altmetric has tracked 156 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 93,038 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.